Aleksey Yefremov's questions to Corteva Inc (CTVA) leadership • Q2 2025
Question
Aleksey Yefremov from KeyBanc Capital Markets asked if Corteva is seeing increased demand for its products as an alternative to Chinese generics, given recent market dynamics.
Answer
CEO Chuck Magro clarified that Corteva does not compete head-to-head with generics, as it serves a different customer base seeking differentiated technology. However, he and EVP Robert King noted that the stabilization of the generic price floor is a healthy indicator for the overall market, particularly in Latin America.